ゲノムバイオマーカーの世界市場に関する洞察と2028年までの予測Global Genomic Biomarkers Market Insights and Forecast to 2028 市場の分析と洞察。ゲノムバイオマーカーの世界市場 ゲノムバイオマーカーの世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率(%)で推移... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。ゲノムバイオマーカーの世界市場ゲノムバイオマーカーの世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率(%)で推移しています。 この健康危機による経済変化を十分に考慮し、2021年にゲノムバイオマーカー世界市場の%を占めたオンコロジーは、2028年には百万米ドルの価値を持ち、COVID-19後の期間に改訂された%のCAGRで成長すると予測されます。一方、診断および研究機関セグメントは、この予測期間を通して%CAGRに変更されています。 中国のゲノムバイオマーカー市場規模は2021年に百万米ドル、北米と欧州のゲノムバイオマーカーはそれぞれ百万米ドルと百万米ドルです。北米の割合は2021年に%、中国とヨーロッパはそれぞれ%と%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%となります。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%である。欧州のゲノムバイオマーカーについては、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。 本レポートは、業界標準の分析精度と高いデータ整合性により、世界のゲノムバイオマーカー市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つよう、優れた試みを行っています。本レポートの購入者は、世界のゲノムバイオマーカー市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。 本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界のゲノムバイオマーカー市場で永続的な成功を収めるための有効なツールになるものと思われます。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のゲノムバイオマーカー市場を詳細に調査するため、独自の業界最高水準の調査分析アプローチを採用しています。 世界のゲノムバイオマーカーの範囲と市場規模 ゲノムバイオマーカー市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界のゲノムバイオマーカー市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。 タイプ別セグメント オンコロジー 循環器系疾患 神経系疾患 その他 用途別セグメント 診断・研究機関 病院 その他 会社別 サーモフィッシャーサイエンティフィック ロシュ エポディア ミリアドジェネティクス ユーロフィンズサイエンティフィック QIAGEN バイオ・ラッド・ラボラトリーズ ジェノミックヘルス リキッドゲノミクス エピゲノミクス AROSアプライド・バイオテクノロジー 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア 北欧諸国 その他の欧州地域 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ラテンアメリカ メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ トルコ サウジアラビア UAE MEAの残りの地域 目次1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oncology 1.2.3 Cardiovascular Diseases 1.2.4 Neurological Diseases 1.2.5 Others 1.3 Market by Application 1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Diagnostic and Research Laboratories 1.3.3 Hospitals 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Genomic Biomarkers Market Perspective (2017-2028) 2.2 Genomic Biomarkers Growth Trends by Region 2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022) 2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028) 2.3 Genomic Biomarkers Market Dynamics 2.3.1 Genomic Biomarkers Industry Trends 2.3.2 Genomic Biomarkers Market Drivers 2.3.3 Genomic Biomarkers Market Challenges 2.3.4 Genomic Biomarkers Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genomic Biomarkers Players by Revenue 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022) 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022) 3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Genomic Biomarkers Revenue 3.4 Global Genomic Biomarkers Market Concentration Ratio 3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021 3.5 Genomic Biomarkers Key Players Head office and Area Served 3.6 Key Players Genomic Biomarkers Product Solution and Service 3.7 Date of Enter into Genomic Biomarkers Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genomic Biomarkers Breakdown Data by Type 4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022) 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028) 5 Genomic Biomarkers Breakdown Data by Application 5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022) 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Genomic Biomarkers Market Size (2017-2028) 6.2 North America Genomic Biomarkers Market Size by Type 6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022) 6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028) 6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028) 6.3 North America Genomic Biomarkers Market Size by Application 6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022) 6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028) 6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028) 6.4 North America Genomic Biomarkers Market Size by Country 6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022) 6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Genomic Biomarkers Market Size (2017-2028) 7.2 Europe Genomic Biomarkers Market Size by Type 7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022) 7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028) 7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028) 7.3 Europe Genomic Biomarkers Market Size by Application 7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022) 7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028) 7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028) 7.4 Europe Genomic Biomarkers Market Size by Country 7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022) 7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028) 8.2 Asia-Pacific Genomic Biomarkers Market Size by Type 8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028) 8.3 Asia-Pacific Genomic Biomarkers Market Size by Application 8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028) 8.4 Asia-Pacific Genomic Biomarkers Market Size by Region 8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Genomic Biomarkers Market Size (2017-2028) 9.2 Latin America Genomic Biomarkers Market Size by Type 9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022) 9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028) 9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028) 9.3 Latin America Genomic Biomarkers Market Size by Application 9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022) 9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028) 9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028) 9.4 Latin America Genomic Biomarkers Market Size by Country 9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022) 9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028) 10.2 Middle East & Africa Genomic Biomarkers Market Size by Type 10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028) 10.3 Middle East & Africa Genomic Biomarkers Market Size by Application 10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028) 10.4 Middle East & Africa Genomic Biomarkers Market Size by Country 10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction 11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022) 11.1.5 Thermo Fisher Scientific Recent Developments 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Genomic Biomarkers Introduction 11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022) 11.2.5 Roche Recent Developments 11.3 Aepodia 11.3.1 Aepodia Company Details 11.3.2 Aepodia Business Overview 11.3.3 Aepodia Genomic Biomarkers Introduction 11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022) 11.3.5 Aepodia Recent Developments 11.4 Myriad Genetics 11.4.1 Myriad Genetics Company Details 11.4.2 Myriad Genetics Business Overview 11.4.3 Myriad Genetics Genomic Biomarkers Introduction 11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022) 11.4.5 Myriad Genetics Recent Developments 11.5 Eurofins Scientific 11.5.1 Eurofins Scientific Company Details 11.5.2 Eurofins Scientific Business Overview 11.5.3 Eurofins Scientific Genomic Biomarkers Introduction 11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022) 11.5.5 Eurofins Scientific Recent Developments 11.6 QIAGEN 11.6.1 QIAGEN Company Details 11.6.2 QIAGEN Business Overview 11.6.3 QIAGEN Genomic Biomarkers Introduction 11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022) 11.6.5 QIAGEN Recent Developments 11.7 Bio-Rad Laboratories 11.7.1 Bio-Rad Laboratories Company Details 11.7.2 Bio-Rad Laboratories Business Overview 11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction 11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022) 11.7.5 Bio-Rad Laboratories Recent Developments 11.8 Genomic Health 11.8.1 Genomic Health Company Details 11.8.2 Genomic Health Business Overview 11.8.3 Genomic Health Genomic Biomarkers Introduction 11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022) 11.8.5 Genomic Health Recent Developments 11.9 Liquid Genomics 11.9.1 Liquid Genomics Company Details 11.9.2 Liquid Genomics Business Overview 11.9.3 Liquid Genomics Genomic Biomarkers Introduction 11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022) 11.9.5 Liquid Genomics Recent Developments 11.10 Epigenomics 11.10.1 Epigenomics Company Details 11.10.2 Epigenomics Business Overview 11.10.3 Epigenomics Genomic Biomarkers Introduction 11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022) 11.10.5 Epigenomics Recent Developments 11.11 AROS Applied Biotechnology 11.11.1 AROS Applied Biotechnology Company Details 11.11.2 AROS Applied Biotechnology Business Overview 11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction 11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022) 11.11.5 AROS Applied Biotechnology Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
SummaryMarket Analysis and Insights: Global Genomic Biomarkers Market Table of Contents1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oncology 1.2.3 Cardiovascular Diseases 1.2.4 Neurological Diseases 1.2.5 Others 1.3 Market by Application 1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Diagnostic and Research Laboratories 1.3.3 Hospitals 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Genomic Biomarkers Market Perspective (2017-2028) 2.2 Genomic Biomarkers Growth Trends by Region 2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022) 2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028) 2.3 Genomic Biomarkers Market Dynamics 2.3.1 Genomic Biomarkers Industry Trends 2.3.2 Genomic Biomarkers Market Drivers 2.3.3 Genomic Biomarkers Market Challenges 2.3.4 Genomic Biomarkers Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genomic Biomarkers Players by Revenue 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022) 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022) 3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Genomic Biomarkers Revenue 3.4 Global Genomic Biomarkers Market Concentration Ratio 3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021 3.5 Genomic Biomarkers Key Players Head office and Area Served 3.6 Key Players Genomic Biomarkers Product Solution and Service 3.7 Date of Enter into Genomic Biomarkers Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genomic Biomarkers Breakdown Data by Type 4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022) 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028) 5 Genomic Biomarkers Breakdown Data by Application 5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022) 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Genomic Biomarkers Market Size (2017-2028) 6.2 North America Genomic Biomarkers Market Size by Type 6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022) 6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028) 6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028) 6.3 North America Genomic Biomarkers Market Size by Application 6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022) 6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028) 6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028) 6.4 North America Genomic Biomarkers Market Size by Country 6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022) 6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Genomic Biomarkers Market Size (2017-2028) 7.2 Europe Genomic Biomarkers Market Size by Type 7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022) 7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028) 7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028) 7.3 Europe Genomic Biomarkers Market Size by Application 7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022) 7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028) 7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028) 7.4 Europe Genomic Biomarkers Market Size by Country 7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022) 7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028) 8.2 Asia-Pacific Genomic Biomarkers Market Size by Type 8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028) 8.3 Asia-Pacific Genomic Biomarkers Market Size by Application 8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028) 8.4 Asia-Pacific Genomic Biomarkers Market Size by Region 8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Genomic Biomarkers Market Size (2017-2028) 9.2 Latin America Genomic Biomarkers Market Size by Type 9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022) 9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028) 9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028) 9.3 Latin America Genomic Biomarkers Market Size by Application 9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022) 9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028) 9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028) 9.4 Latin America Genomic Biomarkers Market Size by Country 9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022) 9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028) 10.2 Middle East & Africa Genomic Biomarkers Market Size by Type 10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028) 10.3 Middle East & Africa Genomic Biomarkers Market Size by Application 10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028) 10.4 Middle East & Africa Genomic Biomarkers Market Size by Country 10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction 11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022) 11.1.5 Thermo Fisher Scientific Recent Developments 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Genomic Biomarkers Introduction 11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022) 11.2.5 Roche Recent Developments 11.3 Aepodia 11.3.1 Aepodia Company Details 11.3.2 Aepodia Business Overview 11.3.3 Aepodia Genomic Biomarkers Introduction 11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022) 11.3.5 Aepodia Recent Developments 11.4 Myriad Genetics 11.4.1 Myriad Genetics Company Details 11.4.2 Myriad Genetics Business Overview 11.4.3 Myriad Genetics Genomic Biomarkers Introduction 11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022) 11.4.5 Myriad Genetics Recent Developments 11.5 Eurofins Scientific 11.5.1 Eurofins Scientific Company Details 11.5.2 Eurofins Scientific Business Overview 11.5.3 Eurofins Scientific Genomic Biomarkers Introduction 11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022) 11.5.5 Eurofins Scientific Recent Developments 11.6 QIAGEN 11.6.1 QIAGEN Company Details 11.6.2 QIAGEN Business Overview 11.6.3 QIAGEN Genomic Biomarkers Introduction 11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022) 11.6.5 QIAGEN Recent Developments 11.7 Bio-Rad Laboratories 11.7.1 Bio-Rad Laboratories Company Details 11.7.2 Bio-Rad Laboratories Business Overview 11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction 11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022) 11.7.5 Bio-Rad Laboratories Recent Developments 11.8 Genomic Health 11.8.1 Genomic Health Company Details 11.8.2 Genomic Health Business Overview 11.8.3 Genomic Health Genomic Biomarkers Introduction 11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022) 11.8.5 Genomic Health Recent Developments 11.9 Liquid Genomics 11.9.1 Liquid Genomics Company Details 11.9.2 Liquid Genomics Business Overview 11.9.3 Liquid Genomics Genomic Biomarkers Introduction 11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022) 11.9.5 Liquid Genomics Recent Developments 11.10 Epigenomics 11.10.1 Epigenomics Company Details 11.10.2 Epigenomics Business Overview 11.10.3 Epigenomics Genomic Biomarkers Introduction 11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022) 11.10.5 Epigenomics Recent Developments 11.11 AROS Applied Biotechnology 11.11.1 AROS Applied Biotechnology Company Details 11.11.2 AROS Applied Biotechnology Business Overview 11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction 11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022) 11.11.5 AROS Applied Biotechnology Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(genomic)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|